Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA: 688506)
156.54
-1.13 (-0.72%)
Sep 6, 2024, 4:00 PM CST
Sichuan Biokin Pharmaceutical Co.,Ltd. Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
Cash & Equivalents | 4,268 | 403.96 | 1,005 | 154.22 | 47.2 | 246.78 | Upgrade
|
Trading Asset Securities | 1,633 | - | - | - | 197.54 | - | Upgrade
|
Cash & Short-Term Investments | 5,901 | 403.96 | 1,005 | 154.22 | 244.74 | 246.78 | Upgrade
|
Cash Growth | 832.52% | -59.79% | 551.49% | -36.99% | -0.83% | 252.75% | Upgrade
|
Accounts Receivable | 92.56 | 137.85 | 267.92 | 134.95 | 226.49 | 309.08 | Upgrade
|
Other Receivables | 59.56 | 3.9 | 5.14 | 2.95 | 0.64 | 0.07 | Upgrade
|
Receivables | 152.12 | 141.75 | 273.06 | 137.9 | 227.13 | 309.16 | Upgrade
|
Inventory | 154.18 | 140.91 | 101.33 | 82.33 | 65.77 | 77.29 | Upgrade
|
Other Current Assets | 171.18 | 89.2 | 47.22 | 49.36 | 33.21 | 25.78 | Upgrade
|
Total Current Assets | 6,378 | 775.82 | 1,426 | 423.81 | 570.85 | 659 | Upgrade
|
Property, Plant & Equipment | 544.93 | 534.79 | 420.26 | 404.98 | 380.91 | 347.96 | Upgrade
|
Other Intangible Assets | 27.26 | 28 | 29.53 | 31.16 | 32.88 | 34.46 | Upgrade
|
Long-Term Deferred Tax Assets | 222.95 | 76.18 | 83.23 | 65.8 | 48.2 | 36.27 | Upgrade
|
Long-Term Deferred Charges | 3.55 | 1.82 | 1.79 | 1.16 | 0.67 | 0.94 | Upgrade
|
Other Long-Term Assets | 8.87 | 8.5 | 30.28 | 24.54 | 8.47 | 12.06 | Upgrade
|
Total Assets | 7,186 | 1,425 | 1,991 | 951.46 | 1,042 | 1,091 | Upgrade
|
Accounts Payable | 176.24 | 160.17 | 128.85 | 45.96 | 67.96 | 56.63 | Upgrade
|
Accrued Expenses | 278.81 | 257.88 | 244.81 | 139.81 | 204.43 | 244.42 | Upgrade
|
Short-Term Debt | 670.73 | 275.12 | 155.13 | 161.23 | 150.21 | 195.04 | Upgrade
|
Current Portion of Long-Term Debt | 271.53 | 174.37 | 30.47 | 0.02 | - | - | Upgrade
|
Current Portion of Leases | 33.64 | 46.13 | 68.82 | 24.23 | - | - | Upgrade
|
Current Income Taxes Payable | 255.22 | 0.01 | 4.96 | 1.54 | 10.31 | 7.37 | Upgrade
|
Current Unearned Revenue | 357.92 | 8.67 | 17.42 | 10.78 | 18.1 | - | Upgrade
|
Other Current Liabilities | 106.05 | 131.48 | 86.74 | 87.75 | 81.44 | 110.65 | Upgrade
|
Total Current Liabilities | 2,150 | 1,054 | 737.2 | 471.32 | 532.45 | 614.12 | Upgrade
|
Long-Term Debt | 169.9 | 183.92 | 239.96 | 50 | - | - | Upgrade
|
Long-Term Leases | 15.75 | 8.65 | 52.95 | 51.42 | - | - | Upgrade
|
Long-Term Unearned Revenue | 11.99 | 15.63 | 13.29 | 31.04 | 37.24 | 28.84 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | - | 0.08 | - | 0.08 | - | Upgrade
|
Other Long-Term Liabilities | 9.36 | 11.19 | 14.05 | 15.81 | 20.14 | 19.51 | Upgrade
|
Total Liabilities | 2,357 | 1,273 | 1,058 | 619.61 | 589.91 | 662.46 | Upgrade
|
Common Stock | 401 | 401 | 401 | 360.9 | 360.9 | 115.94 | Upgrade
|
Additional Paid-In Capital | 861.2 | 858.69 | 858.55 | 14.17 | 14.07 | 253.11 | Upgrade
|
Retained Earnings | 3,557 | -1,109 | -328.45 | -45.98 | 74.01 | 44.01 | Upgrade
|
Comprensive Income & Other | 8.98 | 1.13 | 2.79 | 2.76 | 3.1 | 5.12 | Upgrade
|
Total Common Equity | 4,829 | 151.87 | 933.89 | 331.85 | 452.08 | 418.18 | Upgrade
|
Minority Interest | - | - | - | - | - | 10.04 | Upgrade
|
Shareholders' Equity | 4,829 | 151.87 | 933.89 | 331.85 | 452.08 | 428.22 | Upgrade
|
Total Liabilities & Equity | 7,186 | 1,425 | 1,991 | 951.46 | 1,042 | 1,091 | Upgrade
|
Total Debt | 1,162 | 688.19 | 547.33 | 286.91 | 150.21 | 195.04 | Upgrade
|
Net Cash (Debt) | 4,739 | -284.23 | 457.41 | -132.69 | 94.53 | 51.74 | Upgrade
|
Net Cash Growth | 3811.98% | - | - | - | 82.72% | - | Upgrade
|
Net Cash Per Share | 11.83 | -0.71 | 1.26 | -0.37 | 0.27 | 0.13 | Upgrade
|
Filing Date Shares Outstanding | 401 | 401 | 401 | 360.9 | 344.56 | 386.54 | Upgrade
|
Total Common Shares Outstanding | 401 | 401 | 401 | 360.9 | 344.56 | 386.54 | Upgrade
|
Working Capital | 4,228 | -278.01 | 689.14 | -47.51 | 38.4 | 44.88 | Upgrade
|
Book Value Per Share | 12.04 | 0.38 | 2.33 | 0.92 | 1.31 | 1.08 | Upgrade
|
Tangible Book Value | 4,801 | 123.88 | 904.36 | 300.69 | 419.2 | 383.72 | Upgrade
|
Tangible Book Value Per Share | 11.97 | 0.31 | 2.26 | 0.83 | 1.22 | 0.99 | Upgrade
|
Buildings | 334.76 | 304.56 | 302.23 | 300.82 | 252.7 | 250.33 | Upgrade
|
Machinery | 583.93 | 554.25 | 439.83 | 419.75 | 363.73 | 343.12 | Upgrade
|
Construction In Progress | 26.02 | 81.37 | 67.21 | 18.18 | 76.71 | 21.32 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.